Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

A Combined PET/CT Scanner for Clinical Oncology

Thomas Beyer, David W. Townsend, Tony Brun, Paul E. Kinahan, Martin Charron, Raymond Roddy, Jeff Jerin, John Young, Larry Byars and Ronald Nutt
Journal of Nuclear Medicine August 2000, 41 (8) 1369-1379;
Thomas Beyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Townsend
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Brun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul E. Kinahan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Charron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Roddy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeff Jerin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry Byars
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Nutt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 41, Issue 8
August 1, 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Combined PET/CT Scanner for Clinical Oncology
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Combined PET/CT Scanner for Clinical Oncology
Thomas Beyer, David W. Townsend, Tony Brun, Paul E. Kinahan, Martin Charron, Raymond Roddy, Jeff Jerin, John Young, Larry Byars, Ronald Nutt
Journal of Nuclear Medicine Aug 2000, 41 (8) 1369-1379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Combined PET/CT Scanner for Clinical Oncology
Thomas Beyer, David W. Townsend, Tony Brun, Paul E. Kinahan, Martin Charron, Raymond Roddy, Jeff Jerin, John Young, Larry Byars, Ronald Nutt
Journal of Nuclear Medicine Aug 2000, 41 (8) 1369-1379;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Precision Oncology in Melanoma: Changing Practices
  • Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards
  • Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [18F]FDG PET/CT
  • FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
  • Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population -2019)
  • On the Origin of Hybrid Imaging (perspective on "A Combined PET/CT Scanner for Clinical Oncology" J Nucl Med. 2000;41:1369-1379)
  • PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations
  • Fifty Years of Radiopharmaceuticals
  • Driving the Future of Nuclear Medicine
  • Radiomics: Data Are Also Images
  • The Future of Nuclear Medicine as an Independent Specialty
  • Performance Characteristics of the Digital Biograph Vision PET/CT System
  • Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
  • PET and MRI: Is the Whole Greater than the Sum of Its Parts?
  • Evaluation of Prostate Cancer with 11C-Acetate PET/CT
  • Dixon Sequence with Superimposed Model-Based Bone Compartment Provides Highly Accurate PET/MR Attenuation Correction of the Brain
  • 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
  • Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
  • Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone
  • Reconstruction-Incorporated Respiratory Motion Correction in Clinical Simultaneous PET/MR Imaging for Oncology Applications
  • Combined PET/MR: A Technology Becomes Mature
  • Picture the future: emerging imaging modalities
  • Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies
  • An Integrated Quad-Modality Molecular Imaging System for Small Animals
  • PET/MR Imaging: A Critical Appraisal
  • Principles of PET/MR Imaging
  • Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement
  • The history of cerebral PET scanning: From physiology to cutting-edge technology
  • Introduction
  • Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
  • Multimodality Assessment of Brain Tumors and Tumor Recurrence
  • Whole-Body 18F-FDG PET/CT: The Need for a Standardized Field of View--A Referring-Physician Aid
  • Switching on the Lights for Real-Time Multimodality Tumor Neuroimaging: The Integrated Positron-Emission Tomography/MR Imaging System
  • PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
  • Nonrigid Versus Rigid Registration of Thoracic 18F-FDG PET and CT in Patients with Lung Cancer: An Intraindividual Comparison of Different Breathing Maneuvers
  • 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
  • List Mode-Driven Cardiac and Respiratory Gating in PET
  • Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
  • A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma
  • Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas
  • PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles
  • Latest Advances in Molecular Imaging Instrumentation
  • Dual-Modality Imaging: Combining Anatomy and Function
  • Multimodality Molecular Imaging of Tumor Angiogenesis
  • PET Image Denoising Using a Synergistic Multiresolution Analysis of Structural (MRI/CT) and Functional Datasets
  • VP-PET: A New Imaging Modality?
  • Virtual-Pinhole PET
  • Is There a Role for Positron Emission Tomography in Breast Cancer Staging?
  • A Comparison of the Diagnostic Accuracy of 18F-FDG PET and CT in the Characterization of Solitary Pulmonary Nodules
  • Application of PET/CT in the Development of Novel Anticancer Drugs
  • 18F-FDG PET/CT in Evaluating Non-CNS Pediatric Malignancies
  • Absolute Quantification of Myocardial Blood Flow with 13N-Ammonia and 3-Dimensional PET
  • Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus
  • FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy
  • Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
  • Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006
  • Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
  • Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?
  • Introduction
  • The 2006 Henry N. Wagner Lecture: Of Mice and Men (and Positrons)--Advances in PET Imaging Technology
  • PET/CT in Lymphoma: Prospective Study of Enhanced Full-Dose PET/CT Versus Unenhanced Low-Dose PET/CT
  • 18F-FDG PET/CT of Thymic Epithelial Tumors: Usefulness for Distinguishing and Staging Tumor Subgroups
  • The Role of PET in Lymphoma
  • Positron Emission Tomography As an Imaging Biomarker
  • New Technologies and Directed Agents for Applications of Cancer Imaging
  • PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.
  • SPECT-Guided CT for Evaluating Foci of Increased Bone Metabolism Classified as Indeterminate on SPECT in Cancer Patients
  • Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
  • Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0
  • Performance Test of an LSO-APD Detector in a 7-T MRI Scanner for Simultaneous PET/MRI
  • Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients
  • Optimized Contrast-Enhanced CT Protocols for Diagnostic Whole-Body 18F-FDG PET/CT: Technical Aspects of Single-Phase Versus Multiphase CT Imaging
  • Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
  • Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer
  • Whole-Body 18F-FDG PET/CT in the Presence of Truncation Artifacts
  • PET/CT imaging: detection of choroidal melanoma
  • Attenuation Correction of PET Images with Respiration-Averaged CT Images in PET/CT
  • PET/CT Imaging Artifacts
  • Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
  • Detection of Klatskin's Tumor in Extrahepatic Bile Duct Strictures Using Delayed 18F-FDG PET/CT: Preliminary Results for 22 Patient Studies
  • Detection of Unexpected Additional Primary Malignancies with PET/CT
  • Optimizing Imaging Protocols for Overweight and Obese Patients: A Lutetium Orthosilicate PET/CT Study
  • On the Use of Positioning Aids to Reduce Misregistration in the Head and Neck in Whole-Body PET/CT Studies
  • Do Implanted Pacemaker Leads and ICD Leads Cause Metal-Related Artifact in Cardiac PET/CT?
  • Optimized Intravenous Contrast Administration for Diagnostic Whole-Body 18F-FDG PET/CT
  • Molecular Imaging of Antiangiogenic Agents
  • Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?
  • Is 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer?
  • X-Ray Imaging Physics for Nuclear Medicine Technologists. Part 1: Basic Principles of X-Ray Production
  • Impact of Patient Weight and Emission Scan Duration on PET/CT Image Quality and Lesion Detectability
  • A Lesion Detection Observer Study Comparing 2-Dimensional Versus Fully 3-Dimensional Whole-Body PET Imaging Protocols
  • Comparison of PET, CT, and Dual-Modality PET/CT Imaging for Monitoring of Imatinib (STI571) Therapy in Patients with Gastrointestinal Stromal Tumors
  • Cardiac Pacemakers and Central Venous Lines Can Induce Focal Artifacts on CT-Corrected PET Images
  • Software Approach to Merging Molecular with Anatomic Information
  • PET/CT Imaging: Facts, Opinions, Hopes, and Questions
  • Acquisition Protocol Considerations for Combined PET/CT Imaging
  • To Enhance or Not to Enhance? 18F-FDG and CT Contrast Agents in Dual-Modality 18F-FDG PET/CT
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire